MIRAPEX ER

Peak

pramipexole dihydrochloride

NDAORALTABLET, EXTENDED RELEASE
Approved
Feb 2010
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
3

Clinical Trials (3)

NCT00893841Phase 2Completed

Bipolar Study of Seroquel XR With Pramipexole Dihydrochloride

Started Feb 2009
96 enrolled
Bipolar Depression
NCT01074450Phase 1Completed

Pramipexole Dihydrochloride 0.25 mg Tablets Under Fasting Conditions

Started Feb 2005
24 enrolled
Healthy
NCT01074463Phase 1Completed

Pramipexole Dihydrochloride 0.25 mg Tablets Under Non-Fasting Conditions

Started Feb 2005
24 enrolled
Healthy

Loss of Exclusivity

LOE Date
Sep 8, 2029
42 months away
Patent Expiry
Sep 8, 2029

Patent Records (2)

Patent #ExpiryTypeUse Code
7695734
Apr 26, 2028
Product
8679533
Sep 8, 2029
Product
U-219